Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,963 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Open enrollment, early-phase tilt
Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.
- 279
- recruiting participants now
- 45%
- of trials open to enrollment
- 31
- in Phase 3-4 (later-stage)
- 31
- top sponsor: M.D. Anderson Cancer Center
Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 9 of 13
VOICE: Values and Options in Cancer Care
University of Rochester
NCT01485627
St. Jude Cancer Education for Children Program: Evaluation at 4th-Grade Level
St. Jude Children's Research Hospital
NCT01185093
Behavioral Economic Strategies to Improve PRO Adherence
Abramson Cancer Center at Penn Medicine
NCT06013176
Promoting Smoking Cessation in Carpenters
Washington University School of Medicine
NCT01878214
Yoga in Treating Sleep Disturbance in Cancer Survivors
Gary Morrow
NCT00397930
Electronic Symptom Monitoring Intervention for Hospitalized Patients With Cancer
Massachusetts General Hospital
NCT03396510
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
Amgen
NCT00838201
A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors
Dana-Farber Cancer Institute
NCT00588107
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Medtronic Spinal and Biologics
NCT01871519
MOST EMPOWER: Optimizing An Emotion Regulation Intervention
Wake Forest University Health Sciences
NCT04317417
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
NCT00942968
Black Family Eating Behaviors Study
National Human Genome Research Institute (NHGRI)
NCT02015078
Family Genetics Health Education and Healthy Behaviors
National Human Genome Research Institute (NHGRI)
NCT01498276
A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy
gicare Pharma
NCT01926444
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Pierian Biosciences
NCT00901264
Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample
Stanford University
NCT00568867
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Seattle Nuclear Medicine
NCT01254929
Care Transition Intervention for Hospitalized Patients With Advanced Cancer
Massachusetts General Hospital
NCT05142345
Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool
St. Jude Children's Research Hospital
NCT01152268
Characterizing Lone Parenting: A Multi-institutional Pilot Study of the Perceptions of Support and Perceived Stress of Lone Parents of Children With Cancer
National Institute of Mental Health (NIMH)
NCT00969579
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
Mayo Clinic
NCT04548063
Improving Cancer Patients' Insurance Choices
Washington University School of Medicine
NCT03592433
Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
Maureen Lyon
NCT02693665
Genome Sequencing of Human Cancer Tissues
New Mexico Cancer Research Alliance
NCT02105545
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
Duke University
NCT06278883
Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy
BioDelivery Sciences International
NCT00293020
A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech
NCT01633970
An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death
University of Utah
NCT02112084
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors
Novartis Pharmaceuticals
NCT01231594
Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population
Memorial Sloan Kettering Cancer Center
NCT00615147
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
University of Alabama at Birmingham
NCT03767517
Treating Pain in Children With Cancer: Pain Buddy
University of California, Irvine
NCT03384134
Harnessing Generativity Among Young Adult Cancer Survivors
University of California, Los Angeles
NCT04272346
Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?
University of Florida
NCT00735111
Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)
Memorial Sloan Kettering Cancer Center
NCT00581958
Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors
Jounce Therapeutics
NCT04669899
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
University of Wisconsin, Madison
NCT01954420
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
National Institute of Environmental Health Sciences (NIEHS)
NCT01143519
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors
TetraLogic Pharmaceuticals
NCT01188499
Association Between Cancer and Sarcoidosis
University of Miami
NCT03844698
A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors
GlaxoSmithKline
NCT00880321
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
Medical University of South Carolina
NCT02638298
Lay Health Worker Engage, Educate, and Encourage Patients to Share
Stanford University
NCT03699748
Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy
Memorial Sloan Kettering Cancer Center
NCT02356575
Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer
Massachusetts General Hospital
NCT02891993
Calm for Cancer Sleep Disturbance
Arizona State University
NCT04345068
A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors
Sumitomo Pharma America
NCT02432326
An Intervention to Improve Outcomes in Patients With Advanced Cancer
Yale University
NCT01272024
Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
Bristol-Myers Squibb
NCT01653470
Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors
St. Jude Children's Research Hospital
NCT02501460
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Cancer right now
279 recruiting of 621 indexed (45% open).
Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).
Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Cancer?
PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.